The genomic classification of breast cancers based on gene expression derived from complementary DNA microarrays in the scheme proposed several years ago by Perou et al. categorizes breast cancers into five groups or intrinsic subtypes, luminal A, luminal B, ERBB2-overexpressing, basal-like and normal-like [1,2]. This evidence concerns the gene ERBB2 and breast carcinoma.